Course of serum 25-hydroxyvitamin D3 status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation

Annals of Hematology

Volumn 91, Issue 5, 2012, Pages 759-766

  Urbain, Paul ^a,b   Ihorst, Gabriele ^a   Biesalski, Hans Konrad ^b   Bertz, Hartmut ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Allogeneic hematopoietic cell transplantation; BMT; Influencing factors; Serum 25(OH)D 3; Vitamin D

Indexed keywords

CALCIFEDIOL; CORTICOSTEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGE; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PARENTERAL NUTRITION; PATIENT MONITORING; PRIORITY JOURNAL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; RISK FACTOR; SEX DIFFERENCE; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ALLOTRANSPLANTATION; BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED;

ADULT; AGED; CALCIFEDIOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84861420544     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1365-2     Document Type: Article

References (35)

1. Ovesen L, Brot C, Jakobsen J (2003) Food contents and biological activity of 25-hydroxyvitamin D: a vitamin D metabolite to be reckoned with? Ann Nutr Metab 47(3-4):107-113 (Pubitemid 36578800)
2. Adorini L (2002) 1, 25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. Curr Opin Investig Drugs 3 (10):1458-1463
3. Cantorna MT, Zhu Y, Froicu M, Wittke A (2004) Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80(6 Suppl):1717S-1720S
4. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE (2000) 1 alpha, 25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 87(3):214-220 (Pubitemid 30626429)
5. Perkins SL, Kling SJ, Ross FP, Teitelbaum SL (1995) 1, 25 Dihydroxyvitamin D3 stimulates differentiation of committed murine bone marrow-derived macrophage precursor cells. Endocrinology 136(12):5643-5650 (Pubitemid 3015468)
6. Blutt SE, Allegretto EA, Pike JW, Weigel NL (1997) 1, 25-Dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 138(4):1491-1497 (Pubitemid 27137098)
7. Jiang F, Bao J, Li P, Nicosia SV, Bai W (2004) Induction of ovarian cancer cell apoptosis by 1, 25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem 279 (51):53213-53221 (Pubitemid 40051824)
8. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27(23):3757-3763
9. Newton-Bishop JA, Beswick S, Randerson-Moor J, Chang YM, Affleck P, Elliott F, Chan M, Leake S, Karpavicius B, Haynes S, Kukalizch K, Whitaker L, Jackson S, Gerry E, Nolan C, Bertram C, Marsden J, Elder DE, Barrett JH, Bishop DT (2009) Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Oncol 27 (32):5439-5444
10. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, Fuchs CS (2008) Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26(18): 2984-2991
11. Zhou W, Heist RS, Liu G, Asomaning K, Miller DP, Neuberg DS, Wain JC, Lynch TJ, Christiani DC (2006) Second hand smoke exposure and survival in early-stage non-small-cell lung cancer patients. Clin Cancer Res 12(23):7187-7193
12. Shanafelt TD, Drake MT, Maurer MJ, Allmer C, Rabe KG, Slager SL, Weiner GJ, Call TG, Link BK, Zent CS, Kay NE, Hanson CA, Witzig TE, Cerhan JR (2011) Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117(5): 1492-1498
13. Schimmer AD, Minden MD, Keating A (2000) Osteoporosis after blood and marrow transplantation: clinical aspects. Biol Blood Marrow Transpl 6(2A):175-181
14. Schulte C, Beelen DW, Schaefer UW, Mann K (2000) Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos Int 11(4):344-353 (Pubitemid 30417188)
15. Schulte CM, Beelen DW (2004) Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood 103 (10):3635-3643 (Pubitemid 38596275)
16. Rosenblatt J, Bissonnette A, Ahmad R, Wu Z, Vasir B, Stevenson K, Zarwan C, Keefe W, Glotzbecker B, Mills H, Joyce R, Levine JD, Tzachanis D, Boussiotis V, Kufe D, Avigan D (2010) Immunomodulatory effects of vitamin D: implications for GVHD. Bone Marrow Transpl 45(9):1463-1468
17. Pakkala I, Taskinen E, Pakkala S, Raisanen-Sokolowski A (2001) MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation. Bone Marrow Transpl 27(8):863-867 (Pubitemid 32496421)
18. Kreutz M, Eissner G, Hahn J, Andreesen R, Drobnik W, Holler E (2004) Variations in 1 alpha, 25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation. Bone Marrow Transpl 33(8):871-873 (Pubitemid 38519253)
19. Massenkeil G, Fiene C, Rosen O, Michael R, ReisingerW, Arnold R (2001) Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis. Leukemia 15(11):1701-1705 (Pubitemid 33061836)
20. Duncan CN, Vrooman L, Apfelbaum EM, Whitley K, Bechard L, Lehmann LE (2010) 25-Hydroxy vitamin D deficiency following pediatric hematopoietic stem cell transplant. Biol Blood Marrow Transpl 17:749-753
21. Robien K, Strayer LG, Majhail N, Lazovich D, Baker KS, Smith AR, Mulrooney DA, Burns LJ (2011) Vitamin D status among long-term survivors of hematopoietic cell transplantation. Bone Marrow Transpl (in press)
22. Webb AR, Engelsen O (2006) Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 82(6):1697-1703 (Pubitemid 46158866)
23. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gomez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, MWJS A, Pichard C (2004) Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 23(6):1430-1453 (Pubitemid 39517638)
24. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transpl 15(6):825-828
25. Hintzpeter B, Mensink GB, Thierfelder W, Muller MJ, Scheidt-Nave C (2008) Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62(9):1079-1089
26. Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V (2002) Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women. J Clin Endocrinol Metab 87(5):2024-2032 (Pubitemid 34521485)
27. WoitgeHW, Scheidt-Nave C, Kissling C, Leidig-Bruckner G, Meyer K, Grauer A, Scharla SH, Ziegler R, Seibel MJ (1998) Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. J Clin Endocrinol Metab 83(1):68-75 (Pubitemid 28498312)
28. Need AG, Morris HA, Horowitz M, Nordin C (1993) Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. Am J Clin Nutr 58(6):882-885 (Pubitemid 23353596)
29. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman BA (2002) Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third national health and nutrition examination survey, 1988-1994. Am J Clin Nutr 76(1):187-192 (Pubitemid 34686565)
30. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72(3):690-693 (Pubitemid 30667088)
31. Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs BL (1977) Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 60(1):253-259 (Pubitemid 8145163)
32. Kulak CA, Borba VZ, Bilezikian JP, Silvado CE, Paola L, Boguszewski CL (2004) Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 62(4):940-948 (Pubitemid 40013088)
33. Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL (2005) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev (3):CD000227
34. Epstein S (1996) Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 11 (1):1-7 (Pubitemid 26026737)
35. Marks R, Potthoff K, Hahn J, et al. (2008) Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies. Blood 112:415-425